HealthDay - TUESDAY, July 6 (HealthDay News) -- High concentrations of a blood plasma protein called clusterin may influence the development, severity and progression of Alzheimer's disease, English researchers report.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.